Gage Cannabis Expected To IPO On CSE In Early April

Gage Cannabis has reportedly filed for a direct listing in Canada. Reported this morning by Reuters, the company is expected to direct list on the Canadian Securities Exchange as per undisclosed sources.

The company will look to list on the CSE as a result of its operations being based in the US, where cannabis operations remain federally illegal. Reuters sources have indicated that the company will look to begin trading in the first part of April, under the ticker symbol “GAGE”. A bulletin has yet to be filed by the exchange however.

Gage, which is notably backed by Bruce Linton whom currently is the firms Executive Chairman, currently has operations primarily focused on the state of Michigan where it has 7 locations open under the Gage and Cookies banners along with plans for an additional six as per the firms website.

The announcement follows the news last fall wherein the company was approved for a Tier 2 Regulation A offering by the SEC for a $50.0 million offering. Documents filed at the time had indicated that the company generated revenues of $17.5 million for the six months ended June 30, 2020.

Further information on the listing was not provided.


Information for this briefing was found via Reuters. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Related News

Gage Cannabis Marks April 6 As Go-Public Date

Gage Growth Corp (CSE: GAGE), also known as Gage Cannabis, formally announced this morning that...

Thursday, April 1, 2021, 08:23:02 AM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq...

Tuesday, March 1, 2022, 02:26:00 PM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Electric Vehicle Maker Phoenix Motor Prices US$15.75 Million IPO

Following through its previously announced IPO plan, electric vehicle maker Phoenix Motor Inc. (Nasdaq: PEV)...

Friday, June 10, 2022, 02:19:00 PM